SCHEMBL7998334

SCHEMBL7998334

Cc1cccc(/C=C/S(=O)(=O)N(c2cccc(Cl)c2)S(=O)(=O)/C=C/c2cccc(C)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 1/20 0.46
NFE2L2 Q16236 6/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
FBP1 P09467 2/20 0.42
F2 P00734 1/20 0.40
PPARG P37231 1/20 0.40
ALOX5 P09917 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
LMNA P02545 2/20 0.39
POLB P06746 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
MEN1 O00255 1/20 0.38
HSP90AA1 P07900 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7998331 0.90 NFE2L2 (0.48) PTGES2NFE2L2MAOAMAOBFBP1
SCHEMBL8001632 0.86 MAPT (0.48) NFE2L2MAOAMAOBFBP1PPARG
SCHEMBL8002291 0.83 NFE2L2 (0.60) NFE2L2FBP1
SCHEMBL7990203 0.83 NFE2L2 (0.47) PTGES2NFE2L2MAOAMAOBFBP1
SCHEMBL8002639 0.81 NFE2L2 (0.43) PTGES2NFE2L2MAOAMAOBFBP1
SCHEMBL7998940 0.81 NFE2L2 (0.64) NFE2L2FBP1
SCHEMBL7990162 0.81 ALDH1A1 (0.51) NFE2L2MAOBFBP1LMNAMEN1
SCHEMBL14788778 0.80 POLB (0.50) PTGES2NFE2L2MAOAMAOBF2
SCHEMBL16577588 0.78 POLB (0.53) PTGES2NFE2L2MAOAMAOBF2
SCHEMBL16019064 0.77 POLB (0.52) PTGES2NFE2L2F2PPARGLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009120783-A1 HIGH AFFINITY INHIBITORS OF HEPATITIS C VIRUS NS3/4A PROTEASE THE JOHNS HOPKINS UNIVERSITY (US) 2009-10-01 WO disclosed